Alphyn Biologics
About:
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases.
Website: https://alphynbiologics.com
Top Investors: Angel Physicians Fund, Queen City Angels, Serial Stage Venture Partners
Description:
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.
Total Funding Amount:
$11.8M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cincinnati, Ohio, United States
Founded Date:
2019-01-01
Founders:
Neal Koller
Number of Employees:
1-10
Last Funding Date:
2024-04-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai